CRNO B — Cereno Scientific AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK2.25bn
- SEK2.32bn
Annual cashflow statement for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16 | -16.3 | -27.7 | -48.1 | -99.5 |
| Depreciation | |||||
| Non-Cash Items | 0.974 | 0.228 | 0.156 | 2.48 | 1.42 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.12 | 2.88 | 8.87 | 8.7 | -5.6 |
| Change in Accounts Receivable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.1 | -13.1 | -18.6 | -36.9 | -103 |
| Capital Expenditures | -8.23 | -44.8 | -57.5 | -49.3 | -84.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.008 | — | — | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -8.24 | -44.8 | -57.5 | -49.3 | -84.8 |
| Financing Cash Flow Items | -4.93 | -4.24 | -3.12 | -15.7 | -3.08 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 64.3 | 81.6 | 53.6 | 106 | 229 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 39.9 | 23.6 | -22.6 | 20.1 | 40.4 |